Plain-English translation of NCT06128304 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the best ways to add cervical cancer screening and treatment services into the existing HIV treatment programs that women are already using in Nigeria. Cervical cancer is a serious health risk for women with HIV, and this study wants to figure out how to make screening and care easier to access by combining it with HIV services that women are already receiving.
Many women with HIV in Nigeria are dying from cervical cancer that could be prevented or treated if caught early. While women are getting HIV treatment, there's currently no reliable way to screen for and treat cervical cancer as part of that same care. This trial exists to find the best strategies for making cervical cancer screening a normal, easy part of HIV care so more women can be protected.
You likely qualify if…
You likely don't qualify if…
Depending on which group you're in, you'll receive cervical cancer screening and support through your HIV treatment clinic. Both groups will receive basic services like counseling, education, and help connecting to treatment if needed. One group will also receive additional support through community engagement activities and special cards to help track your care. The study will follow your progress over time to see which approach works best at helping women get screened and treated for cervical cancer.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States
Nigeria
Sponsor
University of California, San Diego
Collaborators
University of Nigeria Nsukka
Enrollment target
~2,436 participants
Started
November 2023
Primary completion
December 2026
Age range
25 Years – 64 Years
Sex
Female only
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Gregory Aarons, PhD
University of California, San Diego
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.